TAMPERE, Finland, June 13, 2023 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has acquired a new CNC machining center to increase the production capacity of RemeOs™ products at its factory in Tampere, Finland. The acquired machine is optimized for the production of magnesium-based implants and especially for the first product from the … Read more
TAMPERE, Finland, June 13, 2023 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has acquired a new CNC machining center to increase the production capacity of RemeOs™ products at its factory in Tampere, Finland. The acquired machine is optimized for the production of magnesium-based implants and especially for the first product from the … Read more
TAMPERE, Finland, May 26, 2023 /PRNewswire/ — The Annual General Meeting of Bioretec Ltd was held on 26 May 2023 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January-31 December 2022 and resolved to discharge the members of the Board of Directors and the CEO from liability … Read more
TAMPERE, Finland, May 26, 2023 /PRNewswire/ — The Annual General Meeting of Bioretec Ltd was held on 26 May 2023 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January-31 December 2022 and resolved to discharge the members of the Board of Directors and the CEO from liability … Read more
Bioretec Ltd Press release 16 May 2023 at 10:00 a.m. EEST TAMPERE, Finland, May 16, 2023 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, announces that Dr. Jeremy Dublon joins the Bioretec team to support Company’s U.S. commercialization strategy from a clinical and regulatory perspective. Dr. Dublon joins the Bioretec team as a … Read more
Bioretec Ltd Press release 16 May 2023 at 10:00 a.m. EEST TAMPERE, Finland, May 16, 2023 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, announces that Dr. Jeremy Dublon joins the Bioretec team to support Company’s U.S. commercialization strategy from a clinical and regulatory perspective. Dr. Dublon joins the Bioretec team as a … Read more